Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03553472 · ClinicalTrials.gov registry record
Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 97
- Enrollment target
NCT03553472 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 97 participants.
The verdict
NCT03553472 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
Inflammatory bowel disease (IBD) patients under the age of 50 can have a greater risk than the general population above age 50. IBD patient are commonly treated with immunosuppression that increases the risk for Herpes Zoster. A new HZ vaccine is available that could decrease the risk of HZ in IBD patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2019-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03553472
The ClinicalTrials.gov registry entry for NCT03553472 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03553472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03553472 about?
NCT03553472 is a clinical study titled "Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster". Inflammatory bowel disease (IBD) patients under the age of 50 can have a greater risk than the general population above age 50. IBD patient are commonly treated with immunosuppression that increases the risk for Herpes Zoster. A new HZ vaccine is available that could decrease the risk of HZ in IBD p...
What is the current status of trial NCT03553472?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2018-01-01. Estimated completion is 2019-05-31.
Who is sponsoring clinical trial NCT03553472?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.